glp-1 receptor agonist and dpp-4 inhibitor combination not recommended do combine inhibitors with agonists guidance SGLT-2 inhibitors, GLP DPP-4 inhibitors for type 2

Our team of professionals at Vive Ageless Weight Loss Center is here to help you lose some extra pounds without any major side effects

One can hypothesize that their effects on glycemic control and reduction in long-term microvascular and macrovascular complications in patients with T2D might be equally beneficial to people with T1D, especially if overweight or obese

The study period on medication or placebo following the lifestyle intervention is 72 weeks (84)

If you are dealing with nausea, fatigue, or other side effects on a GLP-1 medication, please contact us

Hypertension is the most common preventable risk factor for CVDs (including coronary heart disease, heart failure, stroke, myocardial infarction, atrial fibrillation, and peripheral artery disease), chronic kidney disease, and cognitive impairment, and also the main single factor for deaths and disability worldwide (133)

In many places, telehealth doctors and nurses are legally allowed to treat patients across state lines